Question 1

Does PointState Capital own TEVA stock?

Accepted Answer

No. PointState Capital exited its TEVA (Teva Pharmaceutical Industries) position in Q2 2026. Its Q1 2026 13F listed 1,973,782 shares worth $59.5M.

Question 2

How many shares of TEVA does PointState Capital own?

Accepted Answer

None since Q2 2026, when PointState Capital exited the position. Its Q1 2026 13F listed 1,973,782 shares worth $59.5M.

Question 3

What is PointState Capital's TEVA position worth?

Accepted Answer

PointState Capital's TEVA position was worth $59.5M in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is PointState Capital buying or selling TEVA?

Accepted Answer

In Q2 2026, PointState Capital exited its entire TEVA position.

Question 5

When did PointState Capital first buy TEVA?

Accepted Answer

PointState Capital first reported TEVA in its Q1 2024 13F and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$33.88	0
2026-Q1	Decreased	2M	-48.0%	$59.5M	0.8%	$30.12	0
2025-Q4	Decreased	3.8M	-81.7%	$118.4M	1.7%	$31.21	0
2025-Q3	Unchanged	20.7M	0.0%	$418.4M	6.2%	$20.20	0
2025-Q2	Increased	20.7M	+36.9%	$347.1M	5.3%	$16.76	80
2025-Q1	Increased	15.1M	+11.9%	$232.6M	3.4%	$15.37	64
2024-Q4	Increased	13.5M	+38.6%	$298.1M	5.4%	$22.04	80
2024-Q3	Increased	9.8M	+6.7%	$175.8M	3.2%	$18.02	61